USANA Health Sciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
13 Aug 24 | SellUS$240,487 | Paul Jones | Individual | 6,266 | US$38.38 | |
07 Aug 24 | SellUS$26,753 | Gilbert Fuller | Individual | 674 | US$39.69 | |
31 Jul 24 | SellUS$44,430 | John Fleming | Individual | 1,000 | US$44.43 | |
14 Jun 24 | SellUS$712,958 | Myron Wentz | Individual | 15,698 | US$47.79 | |
07 Jun 24 | SellUS$179,857 | Myron Wentz | Individual | 3,700 | US$48.61 | |
22 May 24 | SellUS$132,064 | Paul Jones | Individual | 2,714 | US$48.66 | |
07 May 24 | SellUS$21,849 | Gilbert Fuller | Individual | 490 | US$44.59 | |
07 May 24 | SellUS$232,677 | G. Hekking | Individual | 5,198 | US$44.76 | |
02 May 24 | SellUS$178,717 | Daniel Macuga | Individual | 3,791 | US$47.14 | |
11 Mar 24 | SellUS$539,539 | Kevin Guest | Individual | 11,011 | US$49.00 | |
08 Mar 24 | SellUS$257,022 | Walter Noot | Individual | 5,240 | US$49.05 | |
06 Mar 24 | SellUS$179,066 | Brent Neidig | Individual | 3,810 | US$47.00 | |
05 Mar 24 | SellUS$183,659 | Robert Sinnott | Individual | 3,945 | US$46.56 | |
04 Mar 24 | SellUS$24,096 | Gilbert Fuller | Individual | 491 | US$49.07 | |
04 Mar 24 | SellUS$14,696 | John Fleming | Individual | 300 | US$48.99 | |
01 Mar 24 | SellUS$72,120 | Daniel Macuga | Individual | 1,500 | US$48.08 | |
29 Feb 24 | SellUS$232,234 | P. Foukas | Individual | 4,847 | US$47.91 | |
29 Feb 24 | SellUS$205,872 | David Mulham | Individual | 4,311 | US$47.76 | |
29 Feb 24 | SellUS$23,351 | Peggie Pelosi | Individual | 485 | US$48.15 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
State or Government | 8,664 | 0.0455% |
General Public | 464,712 | 2.44% |
Hedge Funds | 1,149,264 | 6.03% |
Individual Insiders | 7,788,728 | 40.9% |
Institutions | 9,648,204 | 50.6% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,741,345 | US$258.4m | -1.56% | no data | |||
1,809,932 | US$60.4m | 2.24% | no data | |||
1,602,485 | US$53.5m | 1.75% | no data | |||
1,149,264 | US$38.4m | -2.54% | 0.06% | |||
1,049,610 | US$35.0m | 7.47% | 0.07% | |||
718,169 | US$24.0m | 5.12% | no data | |||
544,256 | US$18.2m | 16.5% | 0.04% | |||
435,164 | US$14.5m | 0.64% | no data | |||
297,120 | US$9.9m | 4.54% | no data | |||
208,275 | US$7.0m | 30.4% | no data | |||
207,786 | US$6.9m | 1.13% | 0.01% | |||
194,220 | US$6.5m | 39.4% | no data | |||
179,022 | US$6.0m | -14.3% | no data | |||
149,305 | US$5.0m | -0.06% | no data | |||
124,008 | US$4.1m | 13.5% | 0.01% | |||
116,671 | US$3.9m | 2.87% | no data | |||
110,486 | US$3.7m | -19.8% | 0.01% | |||
107,784 | US$3.6m | 204% | no data | |||
93,627 | US$3.1m | 134% | no data | |||
89,070 | US$3.0m | -8.53% | no data | |||
69,853 | US$2.3m | -0.66% | no data | |||
68,500 | US$2.3m | 2.26% | no data | |||
67,732 | US$2.3m | 0% | 0.6% | |||
52,123 | US$1.7m | -4.43% | no data | |||
47,727 | US$1.6m | -5.43% | no data |
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 03:03 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/28 |
Annual Earnings | 2023/12/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
USANA Health Sciences, Inc. is covered by 9 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Amy Vinson | Avondale Partners |
Scott Van Winkle | Canaccord Genuity |
Linda Bolton-Weiser | D.A. Davidson & Co. |